Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹1,809 Cr₹867 Cr₹903 Cr₹807 Cr₹555 Cr

What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?

The latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA is ₹1,809 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹1,809 Cr
Mar2023₹867 Cr
Mar2022₹903 Cr
Mar2021₹807 Cr
Mar2020₹555 Cr

How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹1,809 Cr
108.67
Mar2023 ₹867 Cr
-4.01
Mar2022 ₹903 Cr
11.87
Mar2021 ₹807 Cr
45.43
Mar2020 ₹555 Cr -

Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹81,001.3 Cr -0.1% -6.4% 63.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,418.0 Cr -1.2% -4.7% 58.1% Stock Analytics
DIVIS LABORATORIES ₹157,680.0 Cr 0.8% 7.1% 73.4% Stock Analytics
CIPLA ₹128,755.0 Cr 2.7% -2.8% 32.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,720.0 Cr 2.3% -2.2% 20.9% Stock Analytics
ZYDUS LIFESCIENCES ₹100,120.0 Cr -0.7% -5.6% 69.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.1%

-6.4%

63.5%

SENSEX

0.6%

-0.8%

25.4%


You may also like the below Video Courses